DR. SAMIR CHAMPAK PATEL M.D. NPI 1174759419

NPI Details

DR. Samir Champak Patel, M.D. is a hematology and oncology internal medicine in Newburgh, NY with 23 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Samir Champak Patel, M.D. NPI is 1174759419. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: CHICAGO COLLEGE OF MEDICINE AND SURGERY
Graduation Year:2002

The provider's business location address is:

611 GIDNEY AVE
NEWBURGH, NY
ZIP 12550-823
Phone: (917) 796-3016
Fax: (845) 561-6168

The NPI 1174759419 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, iron sucrose, 1 mg (HCPCS:J1756)
• Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram (HCPCS:J1442)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Phosphate level (HCPCS:84100)
• Magnesium level (HCPCS:83735)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Uric acid level, blood (HCPCS:84550)
• Ferritin (blood protein) level (HCPCS:82728)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Folic acid level, serum (HCPCS:82746)
• Vitamin d-3 level (HCPCS:82306)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Protein measurement, serum (HCPCS:84165)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Red blood count, manual test (HCPCS:85044)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Injection of drug or substance into vein (HCPCS:96374)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
• Blood test, clotting time (HCPCS:85610)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Ige (immune system protein) level (HCPCS:82785)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Measurement c-reactive protein for detection of infection or inflammation, high sensitivity (HCPCS:86141)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Infusion, normal saline solution, 250 cc (HCPCS:J7050)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Haptoglobin (serum protein) level (HCPCS:83010)
• Hemoglobin a1c level (HCPCS:83036)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
• Urinalysis, manual test (HCPCS:81002)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Acute hepatitis panel (HCPCS:80074)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Bilirubin level, total (HCPCS:82247)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
• Testosterone (hormone) level, total (HCPCS:84403)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Drawing of blood for a medical problem (HCPCS:99195)
• Transitional care management services for problem of high complexity (HCPCS:99496)
• Coagulation assessment blood test, plasma or whole blood (HCPCS:85730)
• Coagulation function measurement, d-dimer; quantitative (HCPCS:85379)
• Blood test, basic group of blood chemicals (calcium, ionized) (HCPCS:80047)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Transitional care management services for problem of moderate complexity (HCPCS:99495)
• Rheumatoid factor level (HCPCS:86431)
• Red blood cell concentration measurement (HCPCS:85014)
• Parathormone (parathyroid hormone) level (HCPCS:83970)
• Thyroxine (thyroid chemical), total (HCPCS:84436)
• Cortisol (hormone) measurement, total (HCPCS:82533)
• Gene analysis (calreticulin), common variants (HCPCS:81219)
• Gene analysis (janus kinase 2) variant (HCPCS:81270)
• Gene analysis (janus kinase 2) targeted sequence analysis (HCPCS:81279)
• Gene analysis (mpl proto-oncogene, thrombopoietin receptor) for detection of common variants (HCPCS:81338)
• Detection test by nucleic acid for multiple types influenza virus (HCPCS:87502)
• Molecular pathology procedure; physician interpretation and report (HCPCS:G0452)
• Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) (HCPCS:G0506)

The enumeration date for this NPI number is 6/1/2009 and was last updated on 1/22/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: